Christopher M. Kramer, MD, FACC

Christopher Kramer, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Cytokinetics(MODEST), Bristol-Myers Squibb Company (SIGNIFICANT), Eli Lilly and Company(MODEST), Xencor(MODEST)

View Full Disclosure